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Comment
A report on boron analogues of phosphonoacetates, showed that these compounds demonstrated significant hypolipidaemic activity in rodents, specifically lowering serum cholesterol and triglyceride levels [1] . The most important compound among these is the title compound, /V-methyl-A''-methyl-(diisopropylphosphonate)aminecyanoborane (1) [2] , trimethylaminecarbomethoxyborane [3] , M/V'-dimethyl-n-octadecylamineborane [4] , boroncontaining tri-and dipeptides [5] , aminecyanoboranes [6] , and tetrakis^-(trimethylamineboranecarboxylato)-bis(trimethylaminecarboxyborane)-dicopper(II) [7] . Our recent results on these compounds show that they lower serum lipids by inhibiting the activities of key regulatory enzymes in the de novo synthesis of cholesterol, for Narayan S. Hosmane et al. [2] , the unambiguous molecular geometries of these derivatives have not been reported to date. Here we report the crystal structure of the title compound (1) that confirms our previous characterization by conventional spectroscopy and other analytical techniques [2] . The crystal structure of 1 is shown in Figure 1 . The P=0, P-O, P-N, N-C and O-C distances in the phosphonoacetate moiety are within the expected region reported for those containing similar moiety [9] , The C-C bond distances in the alkyl moiety show bond anomaly [ 1. 488 (5) 
Crystal Structure of a Hypolipidaemic
Agent: N-Methyl-N'-MethylfDiisopropylphosphoriatejAmine-Cyanoborane.CgH^BNiOjP example, HMG-CoA reductase [2,8], Although, the chemistry and biological activity of these compounds have been well established
Experimental

Synthesis:
The title compound (I) was synthesized from a reaction involving Λ'-methyl-iV'-methyl-(diisopropylphosphonate)amine and trimethylaminecyanoborane and characterized as described previously [2] , 
